Zura Bio (ZURA) Short Interest Ratio & Short Volume

Short interest is the volume of Zura Bio shares that have been sold short but have not yet been closed out or covered. As of May 15th, traders have sold 721,400 shares of ZURA short. 3.81% of Zura Bio's shares are currently sold short. Learn More on Zura Bio's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ZURA shares currently have a short interest ratio of 2.0. Learn More on Zura Bio's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.81% of Zura Bio's floating shares are currently sold short.

Zura Bio saw a increase in short interest in May. As of May 15th, there was short interest totaling 721,400 shares, an increase of 80.1% from the previous total of 400,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Zura Bio currently has issued a total of 43,590,000 shares. Some of Zura Bio's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Zura Bio currently has a public float of 18,950,000 shares.

3.81% of Zura Bio's shares are currently sold short. Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Zura Bio: Coherus BioSciences, Inc. (18.98%), Innate Pharma S.A. (0.09%), Agenus Inc. (15.73%), Acumen Pharmaceuticals, Inc. (1.84%), Compass Therapeutics, Inc. (1.85%), Monte Rosa Therapeutics, Inc. (5.98%), Invivyd, Inc. (9.17%), INmune Bio, Inc. (14.72%), Adaptimmune Therapeutics plc (1.39%), Genfit S.A. (0.18%),

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks.

Short selling ZURA is an investing strategy that aims to generate trading profit from Zura Bio as its price is falling. ZURA shares are trading down $0.32 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Zura Bio occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ZURA, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ZURA, twice per month. The most recent reporting period available is May, 15 2024.